5 things you need to know about the new breast cancer vaccine that could change everything
- Scientists just announced a breakthrough vaccine that trains your immune system to hunt down and destroy triple-negative breast cancer cells before they form tumors.
- Clinical trials show a 70% reduction in recurrence rates for high-risk patients, offering hope for the most aggressive form of the disease which lacks targeted treatments.
- Unlike traditional vaccines, this one uses personalized tumor markers from a patient's own biopsy to create a custom immune response, making it highly effective but expensive to produce.
- The vaccine is being tested in combination with immunotherapy drugs, with early data suggesting it could prevent breast cancer in people with BRCA1 or BRCA2 genetic mutations.
- Experts warn the vaccine is not a cure-all—it targets specific cancer proteins and requires multiple booster shots—but it could slash global breast cancer deaths by 40% within a decade.